MedPath

四川维奥制药有限公司

Ownership
-
Established
1998-01-08
Employees
-
Market Cap
-
Website
http://www.scweiao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

NMPA:37

Drug Approvals

Aceclofenac Enteric-Coated Tablets

Product Name
维朴芬
Approval Number
国药准字H20031249
Approval Date
May 11, 2024
NMPA

Montmorillonite Powder

Product Name
蒙脱石散
Approval Number
国药准字H20093601
Approval Date
Aug 23, 2023
NMPA

肾骨咀嚼片

Approval Number
国药准字Z20090444
Approval Date
Aug 23, 2023
NMPA

Ferri Ammoni Citras Power

Product Name
枸橼酸铁铵泡腾散剂
Approval Number
国药准字H20090106
Approval Date
Aug 23, 2023
NMPA

Domperidone Tablets

Product Name
多潘立酮片
Approval Number
国药准字H20093491
Approval Date
Aug 7, 2023
NMPA

五加更年胶囊

Approval Number
国药准字Z20090581
Approval Date
Jun 12, 2023
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H20184122
Approval Date
May 30, 2023
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H20184124
Approval Date
May 30, 2023
NMPA

Meiformin Hydrochloride Tableis

Product Name
盐酸二甲双胍片
Approval Number
国药准字H20184066
Approval Date
May 30, 2023
NMPA

红金消结片

Approval Number
国药准字Z20080199
Approval Date
Jan 9, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.